BASF to enter medical foods market in the US with DIEM Labs
european pharmaceutical review | November 03, 2017
As part of this agreement, BASF will use its scientific expertise and state-of-the-art manufacturing capabilities to provide a first-to-the-market medical food product to patients with NAFLD. DIEM Labs will market the product to health care professionals in the U.S. and sell it through an online hub.